Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Tesla’s Future Brightens in China with New FSD Testing Approval

Daniel Kim Views  

Tesla’s stocks saw a rise of over 5% following news that the company received approval to test its Full Self-Driving (FSD) system in Shanghai, China.

Tesla’s shares closed at $187.44, a 5.3% increase from the previous trading day on the 17th (local time) at the New York Stock Exchange. The surge is attributed to the rising anticipation for the adoption of autonomous driving in China, following the news of Shanghai’s FSD test approval reported by Bloomberg. Bloomberg also suggested that Hangzhou might potentially approve FSD testing as well.

Tesla has been providing its Autopilot system in China, but the latest FSD system implemented in the U.S. has not been installed due to regulatory restrictions. China requires companies to obtain map-making qualifications before introducing autonomous driving systems. If the company is foreign, it is also required to form a partnership with a Chinese company.

The market is showing expectations that Tesla could increase its sales in China with the launch of FSD. In April, Tesla CEO Elon Musk visited Beijing, China, and met with Chinese Premier Li Qiang, fueling hopes for the introduction of FSD in China.

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[BUSINESS] Latest Stories

  • Honda's NSX Returns: A 1,000-Horsepower Electric Rival to Lexus LFR
  • Honda’s S7 Electric SUV: A Major Player in the Race for EV Dominance
  • Lamborghini's First EV: A 2,000-Horsepower Beast Built for Speed and Emotion
  • Ford Revives Classic Design with the 2025 Bronco Heritage Edition
  • ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible
  • Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

You May Also Like

  • 1
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 2
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 3
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 4
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

  • 5
    This Celebrity Lost 7kg—and Her Diet Includes ...

    LIFESTYLE 

Popular Now

  • 1
    Red vs. White Wine: Which Is Riskier for Cancer? New Study Has the Answer

    LIFESTYLE&nbsp

  • 2
    Breakfast vs. Dinner: Which Meal Should You Load Up On for Better Health?

    LIFESTYLE&nbsp

  • 3
    Eat More Greens—But Skip the Fake Stuff, Scientists Warn

    LIFESTYLE&nbsp

  • 4
    Veggies vs. IBD: New Research Says the Right Diet Might Be a Game-Changer

    LIFESTYLE&nbsp

  • 5
    Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown

    LIFESTYLE&nbsp

Must-Reads

  • 1
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 2
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 3
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 4
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE 

  • 5
    This Celebrity Lost 7kg—and Her Diet Includes ...

    LIFESTYLE 

Popular Now

  • 1
    Red vs. White Wine: Which Is Riskier for Cancer? New Study Has the Answer

    LIFESTYLE 

  • 2
    Breakfast vs. Dinner: Which Meal Should You Load Up On for Better Health?

    LIFESTYLE 

  • 3
    Eat More Greens—But Skip the Fake Stuff, Scientists Warn

    LIFESTYLE 

  • 4
    Veggies vs. IBD: New Research Says the Right Diet Might Be a Game-Changer

    LIFESTYLE 

  • 5
    Eli Lilly Moves First in India, Beats Novo in Obesity Drug Showdown

    LIFESTYLE